New chief Pamela Rendi-Wagner says European Centre for Disease Prevention and Control (ECDC) should do more to combat ...
U.S. stocks reacted positively following the Federal Open Market Committee's announcement in mid-September that it would lower interest rates by 50 basis points, wider than many analysts had ...
HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...
The Belgian medicines agency, an important stakeholder in the revision of the European pharmaceutical legislation, is ...
PLANEGG-MARTINSRIED, Germany I September 27, 2024 I Formycon AG (FSE: FYB, “Formycon”) and its commercialization partner Fresenius Kabi jointly announce that ...
Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...
Greater collaboration between industry, government, policymakers and the NHS will be critical for treatment options in the UK ...
LONDON, UK I4, 2024 I Duke Street Bio Ltd, a precision medicine biotech developing next generation small molecule cancer therapies, is pleased to ...
Committee for Human Medicinal Products (CHMP) recommended approval of five novel medicines at its September meeting ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
EMA’s human medicines committee recommends approval of Henlius’ Hansizhuang to treat extensive-stage small cell lung cancer: Shanghai, China Monday, September 23, 2024, 16:00 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback